JANE STREET GROUP, LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 61 filers reported holding CLEARSIDE BIOMEDICAL INC in Q1 2022. The put-call ratio across all filers is 2.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q2 2023$17,860
+12.0%
15,946
+12.0%
0.00%
Q4 2022$15,940
-91.9%
14,232
-83.5%
0.00%
Q1 2022$197,000
+245.6%
86,216
+314.7%
0.00%
Q4 2021$57,000
-61.7%
20,792
-16.2%
0.00%
Q3 2021$149,000
+43.3%
24,800
-55.2%
0.00%
Q2 2020$104,000
+48.6%
55,348
+33.8%
0.00%
Q1 2020$70,000
-28.6%
41,366
-58.9%
0.00%
Q2 2019$98,000100,5340.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q1 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders